These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

490 related items for PubMed ID: 562781

  • 21. Ovulation inhibition with nafarelin acetate nasal administration for six months.
    Brenner PF, Shoupe D, Mishell DR.
    Contraception; 1985 Dec; 32(6):531-51. PubMed ID: 2936564
    [Abstract] [Full Text] [Related]

  • 22. Plasma profile on pituitary gonadotropins and ovarian steroids in women during 17 alpha-acetoxy- 11 beta-methyl-19-nor-progesterone administration.
    Pérez-Palacios G, Iramain C, Castañeda E, Rojo B, Long DW, Scaglia HE, Gual C.
    Contraception; 1975 Jul; 12(1):37-43. PubMed ID: 1139948
    [Abstract] [Full Text] [Related]

  • 23. Perturbations of the human menstrual cycle by oxymetholone.
    Cox DW, Heinrichs WL, Paulsen AC, Conrad SH, Schiller HS, Hezl MR, Herrmann WL.
    Am J Obstet Gynecol; 1975 Jan 01; 121(1):121-6. PubMed ID: 1115110
    [Abstract] [Full Text] [Related]

  • 24. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
    Kazem R, Messinis LE, Fowler P, Groome NP, Knight PG, Templeton AA.
    Hum Reprod; 1996 Dec 01; 11(12):2585-90. PubMed ID: 9021355
    [Abstract] [Full Text] [Related]

  • 25. Pituitary, ovarian and endometrial effects of progesterone released prematurely during the proliferative phase.
    Shumin X, Johannisson E, Landgren BM, Diczfalusy E.
    Contraception; 1983 Feb 01; 27(2):177-93. PubMed ID: 6851555
    [Abstract] [Full Text] [Related]

  • 26. Differences in hormonal patterns during the first postabortion menstrual cycle after two techniques of termination of pregnancy.
    Blazar AS, Harlin J, Zaidi AA, Diczfalusy E.
    Fertil Steril; 1980 May 01; 33(5):493-500. PubMed ID: 6768597
    [Abstract] [Full Text] [Related]

  • 27. Fourteen-day versus twenty-one-day regimens of intermittent intranasal luteinizing hormone-releasing hormone agonist combined with an oral progestogen as antiovulatory contraceptive approach.
    Lemay A, Faure N.
    J Clin Endocrinol Metab; 1986 Dec 01; 63(6):1379-85. PubMed ID: 2946711
    [Abstract] [Full Text] [Related]

  • 28. Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women.
    Roseff SJ, Kettel LM, Rivier J, Burger HG, Baulieu E, Yen SS.
    Fertil Steril; 1990 Nov 01; 54(5):805-10. PubMed ID: 2226914
    [Abstract] [Full Text] [Related]

  • 29. Effects of postovulatory estradiol benzoate administration on women's ovarian function.
    Oriol-Bosch A, Cortés J.
    Fertil Steril; 1975 May 01; 26(5):405-12. PubMed ID: 1126465
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
    Kekkonen R, Alfthan H, Haukkamaa M, Heikinheimo O, Luukkainen T, Lähteenmäki P.
    Fertil Steril; 1990 Apr 01; 53(4):747-50. PubMed ID: 2108063
    [Abstract] [Full Text] [Related]

  • 33. Effect of daily administration of 0.5 mg. of chlormadinone acetate on plasma levels of follicle-stimulating hormone, luteinizing hormone, and progesterone during the menstrual cycle.
    Saunders DM, Marcus SL, Saxena BB, Beling CG, Connell EB.
    Fertil Steril; 1971 May 01; 22(5):332-44. PubMed ID: 4102481
    [Abstract] [Full Text] [Related]

  • 34. The menstrual cycle in women using an intrauterine device.
    Faundes A, Segal SJ, Adejuwon CA, Brache V, Leon P, Alvarez-Sanchez F.
    Fertil Steril; 1980 Nov 01; 34(5):427-30. PubMed ID: 7439408
    [Abstract] [Full Text] [Related]

  • 35. Estrogen-induced sexual receptivity and localization of 3H-estradiol in brains of female mice: effects of 5 alpha-reduced androgens, progestins and cyproterone acetate.
    Luttge WG, Jasper TW, Gray HE, Sheets CS.
    Pharmacol Biochem Behav; 1977 May 01; 6(5):521-8. PubMed ID: 896889
    [Abstract] [Full Text] [Related]

  • 36. Variable effects of RU 486 on endometrial maintenance in the luteal phase extended by exogenous hCG.
    Croxatto HB, Salvatierra AM, Croxatto HD, Spitz IM.
    Clin Endocrinol (Oxf); 1989 Jul 01; 31(1):15-23. PubMed ID: 2598478
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Studies on ovarian and adrenal steroids at different phases of the menstrual cycle. III. Steroid and lutropin levels before and after the administration of a single contraceptive dose of depot-medroxyprogesterone acetate (DMPA).
    Aedo AR, Landgren BM, Diczfalusy E.
    Contraception; 1981 Aug 01; 24(2):117-35. PubMed ID: 6457729
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.